Literature DB >> 9324355

Complement receptor type 1 (CR1, CD35) is a receptor for C1q.

L B Klickstein1, S F Barbashov, T Liu, R M Jack, A Nicholson-Weller.   

Abstract

Molecular definition of the cellular receptor for the collagen domain of C1q has been elusive. We now report that C1q binds specifically to human CR1 (CD35), the leukocyte C3b/C4b receptor, and the receptor on erythrocytes for opsonized immune complexes. Biotinylated or radioiodinated C1q (*C1q) bound specifically to transfected K562 cells expressing cell surface CR1 and to immobilized recombinant soluble CR1 (rsCR1). *C1q binding to rsCR1 was completely inhibited by unlabeled C1q and the collagen domain of C1q and was partially inhibited by C3b dimers. Kinetic analysis in physiologic saline of the interaction of unlabeled C1q with immobilized rsCR1 using surface plasmon resonance yielded an apparent equilibrium dissociation constant (K[eq2]) of 3.9 nM. Thus, CR1 is a cellular C1q receptor that recognizes all three complement opsonins, namely, C1q, C3b, and C4b.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9324355     DOI: 10.1016/s1074-7613(00)80356-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  61 in total

Review 1.  C1q receptors.

Authors:  P Eggleton; A J Tenner; K B Reid
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 2.  Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus.

Authors:  J S Navratil; J M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 3.  Complementing the inflammasome.

Authors:  Martha Triantafilou; Timothy R Hughes; Bryan Paul Morgan; Kathy Triantafilou
Journal:  Immunology       Date:  2016-02       Impact factor: 7.397

4.  CR1-mediated ATP release by human red blood cells promotes CR1 clustering and modulates the immune transfer process.

Authors:  Mark I Melhorn; Abigail S Brodsky; Jessica Estanislau; Joseph A Khoory; Ben Illigens; Itaru Hamachi; Yasutaka Kurishita; Andrew D Fraser; Anne Nicholson-Weller; Elena Dolmatova; Heather S Duffy; Ionita C Ghiran
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

5.  Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection.

Authors:  Christopher B Brooke; Alexandra Schäfer; Glenn K Matsushima; Laura J White; Robert E Johnston
Journal:  J Gen Virol       Date:  2011-12-28       Impact factor: 3.891

Review 6.  Macrophage receptors for Mycobacterium tuberculosis.

Authors:  J D Ernst
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

7.  A complement receptor-1 polymorphism with high frequency in malaria endemic regions of Asia but not Africa.

Authors:  B N Thomas; B Donvito; I Cockburn; T Fandeur; J A Rowe; J H M Cohen; J M Moulds
Journal:  Genes Immun       Date:  2005-02       Impact factor: 2.676

8.  Severity of malaria in relation to a complement receptor 1 polymorphism: a case-control study.

Authors:  Rebecca Tettey; Patrick Ayeh-Kumi; Prudence Tettey; George O Adjei; Richard H Asmah; Daniel Dodoo
Journal:  Pathog Glob Health       Date:  2015-04-27       Impact factor: 2.894

9.  Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System.

Authors:  Kazi Abdus Salam; Richard Y Wang; Teresa Grandinetti; Valeria De Giorgi; Harvey J Alter; Robert D Allison
Journal:  Hepatology       Date:  2018-11-01       Impact factor: 17.425

Review 10.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.